May 19, 2026 04:45PM
May 14, 2026 04:10PM
May 13, 2026 04:01PM
May 6, 2026 04:01PM
Apr 21, 2026 08:30AM
Apr 21, 2026 08:30AM
Mar 31, 2026 04:05PM Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Mar 30, 2026 04:05PM
Mar 30, 2026 04:05PM
Mar 25, 2026 04:01PM
Mar 18, 2026 08:30AM
Feb 23, 2026 09:24AM
Feb 23, 2026 09:24AM
Feb 23, 2026 08:30AM Fortress Biotech unit Cyprium agrees to sell rare disease voucher for $205M
Feb 23, 2026 08:30AM
Feb 23, 2026 08:00AM
Feb 23, 2026 08:00AM
Jan 13, 2026 07:45AM
Jan 13, 2026 07:45AM
Jan 12, 2026 05:11PM
Dec 15, 2025 08:03AM FDA accepts resubmitted drug application for rare pediatric disease
Dec 15, 2025 08:00AM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM
Nov 14, 2025 08:30AM
Nov 12, 2025 04:01PM
Nov 5, 2025 08:30AM
Oct 24, 2025 08:30AM Journey Medical presents Emrosi clinical trial data at dermatology conference
Oct 24, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 8, 2025 08:30AM
Oct 2, 2025 06:47AM
Oct 1, 2025 08:00AM
Sep 3, 2025 08:30AM Journey Medical Corporation to Participate in September 2025 Investor Conferences
Aug 18, 2025 08:30AM
Aug 14, 2025 04:05PM
Aug 12, 2025 04:01PM
Aug 7, 2025 08:30AM
Aug 7, 2025 08:30AM
Aug 5, 2025 04:01PM
Jul 14, 2025 08:31AM Journey Medical expands Emrosi payer coverage to 65% of commercial lives
Jul 14, 2025 08:30AM
Jul 7, 2025 08:32AM
Jul 7, 2025 08:30AM
Jun 24, 2025 08:31AM
Jun 24, 2025 08:30AM
Jun 20, 2025 08:32AM
Jun 20, 2025 08:30AM Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
Jun 9, 2025 08:30AM

322,215 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All